SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

A room full of agents is not a software factory

Why are AI providers lowering prices even as usage expands?

OpenAI hit pause, attackers haven’t. Here’s what security leaders must do next

Claude Code creator's prompting formula: Say what you want and let AI figure out the rest

Buzz

Most popular

Daily

Weekly

1

Israel loses $1 billion Apache deal after failing to find $288 million in funding

2

Nvidia hits record $5.65 trillion as SpaceX seeks $40 billion to buy its AI chips

3

Israel to end private recruitment of construction workers from India and Sri Lanka

4

Israeli startup raises $5 million to rethink one of surgery's most invasive procedures

5

Foreign investors are pulling back from Israeli stocks as appetite for banks collapses

Sanofi

6 stories about Sanofi

CTech The growth conference Katie Kushnir Ventura

“People learn, people develop”: Sanofi Israel’s HR Head sees “only positives” in AI

10.06.25|Amy Shapiro

Speaking with CTech at the Israel Growth Conference, Sanofi Israel’s Katie Kushnir Ventura shared how the pharmaceutical giant is using AI to improve its operations and support employees through upskilling and easier access to digital resources.

מגזין מנהלים ריצ'רד פרנסיס מנכ"ל טבע

Teva’s stock surge comes to a halt, falling 14% amid weak 2025 outlook

30.01.25|Sophie Shulman

Despite a strong 80% gain in 2024, Teva’s stock dropped after the company revealed disappointing profitability and cash flow forecasts.

ריצרד פרנסיס נשיא ו מנכל חברה חברת טב

Teva’s 10-year turnaround takes shape with stunning trial results

18.12.24|Sophie Shulman

Duvakitug signals a brighter future for the Israeli pharma giant.

מפגש עיתונאים ראשון עם נשיא ומנכל חברת טבע ריצ'רד פרנסיס

Teva shares jump as its most promising drug shows exceptional trial results

17.12.24|Sophie Shulman

Duvakitug, designed to treat colitis and Crohn’s disease, exceeded expectations and positions Teva to compete in the $28 billion global market for inflammatory bowel disease treatments.

Nucleai raises $33 million for spatial biology drug development platform

22.03.22|Meir Orbach

The technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs

עומרי שור מנכ"ל מדיסייף

Medisafe raises $30 million in Series C led by pharma giant Sanofi

25.02.21|Meir Orbach

The company expanded its platform in 2020 with the launch of Medisafe Care Connector, which digitally connects patients and doctors